Skip to main content
Icade logo

Icade — Investor Relations & Filings

Ticker · ICAD ISIN · FR0000035081 LEI · 969500UDH342QLTE1M42 PA Real estate activities
Open in API
Filings indexed 1,089 across all filing types
Latest filing 2020-02-17 Earnings Release
Country FR France
Listing PA ICAD

About Icade

https://www.icade.fr/en/

Icade is an integrated real estate company that operates as both a property investor and a property developer. The company's investment division focuses on a portfolio of commercial properties, including offices and business parks, as well as healthcare facilities. As a developer, Icade designs, builds, and manages a diverse range of assets, from residential properties to large-scale urban projects. A central element of its strategy is the creation of innovative and sustainable real estate solutions, with an emphasis on developing low-carbon buildings and functional urban spaces for future communities.

Recent filings

Filing Released Lang Actions
ICADE - POSITIVE FY 2019 RESULTS
Earnings Release Classification · 1% confidence The document is a press release dated February 17, 2020, detailing 'POSITIVE FY 2019 RESULTS'. It contains key financial metrics for the full year 2019, including Revenue, Net Current Cash Flow (NCCF), Net Profit, EPRA NAV, and proposed dividend. It also provides detailed segment performance (Property Investment, Healthcare, Property Development) and outlook for 2020. This structure—a summary of annual financial performance released shortly after the fiscal year end—is characteristic of an Earnings Release (ER). While it contains comprehensive data, it is presented as a high-level summary announcement rather than the full, audited Annual Report (10-K) or a comprehensive Interim Report (IR). The mention of the Board approving financial statements on Feb 14, 2020, confirms this is the initial public release of the annual figures. FY 2019
2020-02-17 English
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL CONFORMEMENT AUX DISPOSITIONS DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AMF ET L.233-8-II DU CODE
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated February 10, 2020, titled 'INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE...' which explicitly states it is in compliance with Article 223-16 of the AMF General Regulation and L.233-8-II of the Commercial Code. It provides a table detailing the total number of shares and voting rights as of January 31, 2020. This type of mandatory monthly disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement in France, often related to capital structure changes or transparency mandates. While it relates to share capital, it is not a general share issue announcement (SHA) or a transaction in own shares (POS). It is a specific regulatory disclosure about the capital structure count. Given the options, this specific type of mandatory monthly capital/voting rights disclosure does not perfectly align with the provided definitions, but it is a regulatory announcement. However, the closest fit among the options that deals with share counts and capital structure transparency, especially when it's a routine monthly update, is often categorized under general regulatory filings or sometimes related to capital changes. Since it is a formal, periodic disclosure mandated by regulation (AMF/Code de Commerce) detailing the current share count, and it is not a dividend notice, director dealing, or a major shareholding notification crossing a threshold, it falls best under the general 'Regulatory Filings' (RNS) as a specific, non-standard report, or potentially related to capital structure. Given the nature of mandatory periodic reporting on share count, RNS is the most appropriate fallback for a specific regulatory disclosure not covered elsewhere. It is not an ER, IR, or 10-K. It is a formal regulatory update.
2020-02-10 French
MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it provides 'MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES, PROVIDED PURSUANT TO ARTICLE 223-16 OF THE GENERAL REGULATION OF THE FRENCH FINANCIAL MARKET AUTHORITY AND ARTICLE L. 233-8-II OF THE FRENCH COMMERCIAL CODE'. This content, detailing the total number of issued shares and voting rights on a specific date (January 31, 2020), is a mandatory regulatory disclosure in France concerning share capital structure and ownership transparency. This type of filing, which reports changes in the total number of shares and voting rights, is best classified under 'Major Shareholding Notification' (MRQ) or potentially a general 'Regulatory Filing' (RNS). Given the specific nature of reporting voting rights and share counts monthly, MRQ is the most precise fit among the provided options, as it relates directly to ownership structure changes, even if it's a routine regulatory update rather than a specific shareholder crossing a threshold.
2020-02-10 English
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL CONFORMEMENT AUX DISPOSITIONS DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AMF ET L.233-8-II DU CODE
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated January 3, 2020, providing the 'INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE' (Monthly information relating to the total number of shares and voting rights) as of December 31, 2019, referencing French regulations (AMF and Code de Commerce). This type of regular disclosure regarding the total number of shares and voting rights, often required monthly or quarterly, is a specific regulatory filing. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). Since it is a mandatory, periodic regulatory disclosure that doesn't fit the more specific categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification), it falls best under the general 'Regulatory Filings' category (RNS) or potentially a specific capital/share structure update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for mandatory, periodic regulatory updates that aren't financial statements or management discussions. However, since the content specifically details the capital structure (total shares and voting rights), it is closely related to share capital changes. Reviewing the definitions, none perfectly match a 'Monthly Share Capital Disclosure'. RNS is the best fallback for mandatory regulatory announcements. If a more specific code existed for 'Share Capital/Voting Rights Disclosure', that would be preferred. Based on the provided list, RNS is the most suitable general regulatory filing category.
2020-01-03 French
MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated January 3rd, 2020, providing a monthly update on the total number of voting rights and shares as of December 31, 2019. It explicitly references French regulatory articles (Article 223-16 of the AMF General Regulation and Article L. 233-8-II of the Commercial Code) which mandate this specific disclosure. This type of mandatory periodic disclosure regarding share capital structure and voting rights does not fit neatly into the primary financial report categories (10-K, IR, ER). While it relates to capital structure, it is a specific regulatory disclosure about voting rights, which is often categorized under general regulatory announcements or specific capital change notifications. Given the options, this is a mandatory regulatory filing concerning share structure, but it is not a general share issue (SHA) or a transaction in own shares (POS). It is a specific monthly disclosure required by market authorities. Since there is no specific code for 'Monthly Voting Rights Disclosure', and it is a formal regulatory announcement, the most appropriate general category is Regulatory Filings (RNS), as it is a mandatory filing that doesn't fit the other specific financial or corporate action codes. However, looking closely at the definitions, the content is purely about the number of shares and voting rights, which is a fundamental aspect of capital structure reporting. If we consider 'SHA' (Share Issue/Capital Change), this disclosure is a direct consequence of the current capital structure. Given the highly specific nature of the required disclosure (voting rights count), and its regulatory origin, RNS is the safest fallback. If we must choose a more specific code, none fit perfectly, but RNS covers general regulatory announcements.
2020-01-03 English
CP - LA FONCIERE SANTE D’ICADE FINALISE 3 OPERATIONS POUR 315 M€
M&A Activity Classification · 1% confidence The document is a press release ("COMMUNIQUÉ DE PRESSE") dated December 19, 2019, detailing three recent real estate acquisition/finalization operations by Icade Santé (a healthcare real estate company) in Germany, Italy, and France, totaling €315M. This type of announcement, focusing on specific corporate transactions (acquisitions, investments) and providing key financial figures and operational updates outside of a mandated periodic report (like 10-K or IR), is best classified as a general corporate announcement. Since it details significant investment activity and capital deployment, it aligns closely with 'Capital/Financing Update' (CAP). However, given the nature of the announcement—a press release detailing completed transactions and investment strategy execution—and the lack of a specific regulatory form number, it functions as a significant corporate update. It is not an Earnings Release (ER), Interim Report (IR), or a formal M&A announcement (TAR). It is a direct announcement of capital deployment/investment activity, making 'CAP' the most appropriate fit among the specific options, although 'RNS' (Regulatory Filings/General Announcement) is a close secondary option if CAP were too narrow. Given the focus on investment size and financing strategy execution, CAP is selected.
2019-12-19 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.